Each year, Milliman studies the trends in mergers and acquisitions (M&A) of global health and life insurance
companies, with a particular focus on data and deals in North America, Europe, and Asia. In 2022, life and health insurance transaction activity was down sharply. Our research points to the likely causes and projects the landscape for future life and health insurance transaction activity, with consideration of demand from traditional insurers, private equity investors, and other key players in the market.
See mergers and acquisitions (M&A) by country, and more deal data
We present the highlights of our analysis below. Download the full report for more details, including a country-by-country breakdown of deal specifics, key players, and a future outlook.
Worldwide statistics: Life and health insurance mergers and acquisitions
Life and health insurers saw significantly less M&A activity in 2022 than the year before. High inflation, geopolitical conflict, and other pressures likely inspired caution among buyers and sellers, although some decline in activity was likely after a busy 2021.
Globally, there were 122 deals announced in 2022, versus 171 in 2021. Total publicly announced deal values were US$19.8 billion in 2022, down from US$70.7 billion in 2021.
0
%Total reported global deal volume in 2022
0
%Total reported global deal value in 2022
North America
Deals
29
from 57 in 2021
Total publicly announced transaction value
$2.7 billion
from $37.2 billion in 2021
Europe
Deals
34
from 51 in 2021
Total publicly announced transaction value
$12.7 billion
from $14.9 billion in 2021